Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest).

Saved in:
Bibliographic Details
Title: Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest).
Authors: Modlin IM; Yale University School of Medicine, New Haven, CT, USA. imodlin@irvinmodlin.com., Kidd M; Wren Laboratories, Branford, CT, USA., Oberg K; University Hospital, Uppsala, Sweden., Falconi M; IRCCS San Raffaele Scientific Institute, Milan, Italy., Filosso PL; University of Torino, Torino, Italy., Frilling A; Imperial College London, London, UK., Malczewska A; Medical University of Silesia, Katowice, Poland., Salem R; Yale University School of Medicine, New Haven, CT, USA., Toumpanakis C; Royal Free Hospital, London, UK., Laskaratos FM; Royal Free Hospital, London, UK., Partelli S; IRCCS San Raffaele Scientific Institute, Milan, Italy., Roffinella M; University of Torino, Torino, Italy., von Arx C; Imperial College London, London, UK., Kudla BK; Medical University of Silesia, Katowice, Poland., Bodei L; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Drozdov IA; Wren Laboratories, Branford, CT, USA., Kitz A; Wren Laboratories, Branford, CT, USA.
Source: Annals of surgical oncology [Ann Surg Oncol] 2021 Nov; Vol. 28 (12), pp. 7506-7517. Date of Electronic Publication: 2021 May 18.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1534-4681
DOI:10.1245/s10434-021-10021-1